Europe - FRA:SRT - DE0007165607 - Common Stock
The current stock price of SRT.DE is 192.6 EUR. In the past month the price increased by 19.33%. In the past year, price increased by 0.21%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.95 | 181.23B | ||
| DAP.DE | DANAHER CORP | 28.35 | 134.40B | ||
| LO3.DE | LONZA GROUP AG-REG | 37.36 | 43.89B | ||
| QTS.DE | IQVIA HOLDINGS INC | 18.25 | 30.57B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 59.91 | 20.41B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 59.74 | 20.35B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 51.82 | 17.69B | ||
| ILU.DE | ILLUMINA INC | 23.8 | 13.06B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.53 | 11.49B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 16.94 | 11.11B | ||
| QIA.DE | QIAGEN N.V. | 20.37 | 8.92B | ||
| 1BRKR.MI | BRUKER CORP | 16.34 | 5.00B |
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
SARTORIUS AG
Otto-Brenner-Str. 20
Goettingen NIEDERSACHSEN DE
Employees: 13573
Phone: 495513080
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
The current stock price of SRT.DE is 192.6 EUR. The price increased by 0.42% in the last trading session.
SARTORIUS AG (SRT.DE) has a dividend yield of 0.38%. The yearly dividend amount is currently 0.74.
SRT.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
SRT.DE stock is listed on the Deutsche Boerse Ag exchange.
SARTORIUS AG (SRT.DE) operates in the Health Care sector and the Life Sciences Tools & Services industry.
SARTORIUS AG (SRT.DE) has a market capitalization of 14.42B EUR. This makes SRT.DE a Large Cap stock.
ChartMill assigns a technical rating of 8 / 10 to SRT.DE. When comparing the yearly performance of all stocks, SRT.DE is one of the better performing stocks in the market, outperforming 71.62% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE. SRT.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SRT.DE reported a non-GAAP Earnings per Share(EPS) of 4.56. The EPS increased by 59.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.8% | ||
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| Debt/Equity | 1.28 |
8 analysts have analysed SRT.DE and the average price target is 257.81 EUR. This implies a price increase of 33.86% is expected in the next year compared to the current price of 192.6.
For the next year, analysts expect an EPS growth of 23.27% and a revenue growth 5.14% for SRT.DE